Spike International Trade Company Renamed Spike Supply Chain Company "Online"
Release time:
2022-12-04
News from our newspaper 10# February 27 , Zhejiang Jianfeng International Trade Co., Ltd. officially changed its name to Zhejiang Jianfeng Supply Chain Co., Ltd.
In 2000, the group company invested in the establishment of Zhejiang Jianfeng Import and Export Company to develop the foreign trade market. In November, 2002 , due to the need to set up Jinhua public bonded warehouse, the company also invested in the establishment of Jinhua Zhezhong International Storage and Trade Co., Ltd.; In 2004 , for the purpose of business integration, the import and export company was canceled, while the relevant business was merged into "Zhejiang Central Storage " , "Zhejiang Central Storage " was renamed Zhejiang Jianfeng International Trade Co., Ltd., forming a business operation structure of warehousing logistics and import and export trade. After years of development and the adjustment of business focus, the scale of warehousing logistics and futures delivery warehouse business of international trading companies has been expanding, and the business volume has repeatedly reached new highs, and the name of the enterprise does not match the actual main business. In order to better expand the business and realize the demand of enterprise value, the group company has made a decision to change the enterprise name after full demonstration. In the current logistics industry, supply chain, integration, digitalization, platformization, and multimodal transportation have become the development direction. The standardization, standardization, and integrated high-quality development of the logistics market industry has become actual demand. The country is Building a new development pattern with the domestic large cycle as the main body and the domestic and international double cycles promoting each other. The name change, on the one hand, is the need of business development, which brings convenience to the implementation of development strategies such as expanding commodity (futures) warehousing and logistics business and integrating supply chain business. On the one hand, it is the need of specific work to eliminate customers' doubts about
"doing both warehousing and trade " , enhance their sense of identity and promote cooperation, at the same time, it is conducive to promoting the integration and linkage between enterprises and competent departments and industry associations. (Huang Zhiyu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31